- Home
- ATLCP vs WGSWW Comparison
ATLCP vs WGSWW Comparison
Compare ATLCP & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATLCP
- WGSWW
- Stock Information
- Founded
- ATLCP N/A
- WGSWW N/A
- Country
- ATLCP United States
- WGSWW United States
- Employees
- ATLCP 386
- WGSWW 1000
- Industry
- ATLCP Finance: Consumer Services
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- ATLCP Finance
- WGSWW Technology
- Exchange
- ATLCP Nasdaq
- WGSWW Nasdaq
- Market Cap
- ATLCP N/A
- WGSWW N/A
- IPO Year
- ATLCP N/A
- WGSWW 2020
- Fundamental
- Price
- ATLCP $23.65
- WGSWW $0.19
- Analyst Decision
- ATLCP
- WGSWW
- Analyst Count
- ATLCP 0
- WGSWW 0
- Target Price
- ATLCP N/A
- WGSWW N/A
- AVG Volume (30 Days)
- ATLCP N/A
- WGSWW N/A
- Earning Date
- ATLCP N/A
- WGSWW N/A
- Dividend Yield
- ATLCP N/A
- WGSWW N/A
- EPS Growth
- ATLCP N/A
- WGSWW N/A
- EPS
- ATLCP N/A
- WGSWW N/A
- Revenue
- ATLCP N/A
- WGSWW N/A
- Revenue This Year
- ATLCP N/A
- WGSWW N/A
- Revenue Next Year
- ATLCP N/A
- WGSWW N/A
- P/E Ratio
- ATLCP N/A
- WGSWW N/A
- Revenue Growth
- ATLCP N/A
- WGSWW N/A
- 52 Week Low
- ATLCP N/A
- WGSWW N/A
- 52 Week High
- ATLCP N/A
- WGSWW N/A
- Technical
- Relative Strength Index (RSI)
- ATLCP 67.74
- WGSWW N/A
- Support Level
- ATLCP $23.15
- WGSWW N/A
- Resistance Level
- ATLCP $23.90
- WGSWW N/A
- Average True Range (ATR)
- ATLCP 0.22
- WGSWW 0.00
- MACD
- ATLCP 0.08
- WGSWW 0.00
- Stochastic Oscillator
- ATLCP 81.20
- WGSWW 0.00
About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.